Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Low systemic flow as measured by Doppler-echocardiography has been associated with poor
neurological outcome. Yet, it has not been systematically evaluated whether the treatment of
this hemodynamic condition is beneficial or not. This study aims to evaluate if treating low
systemic flow in preterm infants with dobutamine has any effect on the cerebral circulation
and in newborn prognosis.